Paper7520105
Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.
Lancet, 1994. Cited by 387 papers, by iCite.
Cite this record
ConductScience Library. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Papers, record 7520105. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7520105
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.
- PubMed
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclosporine | Major topic |
| Graft Rejection | Major topic |
| Immunosuppression Therapy | Major topic |
| Liver Transplantation | Major topic |
| Tacrolimus | Major topic |
| Acute Disease | |
| Adolescent | |
| Adrenal Cortex Hormones | |
| Adult | |
| Aged | |
| Chronic Disease | |
| Female | |
| Graft Survival | |
| Humans | |
| Incidence | |
| Infections | |
| Male | |
| Middle Aged | |
| Survival Rate |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04657562 | The New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma | Background |
Source ClinicalTrials.gov
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 7523805 | Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection. | https://conductscience.org/library/papers/7523805 | PubMed |
| Comment in | 7523807 | Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection. | https://conductscience.org/library/papers/7523807 | PubMed |
Cited by118
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 387 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42840765 | Calcineurin inhibitor monitoring in allogeneic hematopoietic cell transplantation: time to move beyond solid organ transplant paradigms. | Front Immunol | 2026 | https://conductscience.org/library/papers/42840765 | PubMed |
| 42604426 | Comparison in Patients' Adherence, Adverse Effects, and Clinical Outcomes Among Liver Transplant Recipients Using Immediate-Release Tacrolimus (Prograf®) Versus Extended-Release Tacrolimus (Advagraf®): First Report from Iran. | Arch Iran Med | 2026 | https://conductscience.org/library/papers/42604426 | PubMed |
| 41312559 | Post-liver transplant mortality in Canada: A retrospective analysis and quality assurance study in British Columbia. | Can Liver J | 2025 | https://conductscience.org/library/papers/41312559 | PubMed |
| 40960492 | Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Developing During Tacrolimus Treatment: A Case Series. | Muscle Nerve | 2025 | https://conductscience.org/library/papers/40960492 | PubMed |
| 40142628 | Maintenance Immunosuppression in Kidney Transplantation: A Review of the Current Status and Future Directions. | J Clin Med | 2025 | https://conductscience.org/library/papers/40142628 | PubMed |
| 39898010 | Swallowed Topical Tacrolimus Induces Clinical and Histological Remission in a Subset of Patients with Severe Lymphocytic Esophagitis. | Inflamm Intest Dis | 2025 | https://conductscience.org/library/papers/39898010 | PubMed |
| 38774214 | Mechanism of tacrolimus in the treatment of lupus nephritis. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38774214 | PubMed |
| 38137854 | Tacrolimus Maintains the Balance of Neutrophil Extracellular Traps by Inducing DNA Methylation of Neutrophils to Reduce Immune Rejection. | Life (Basel) | 2023 | https://conductscience.org/library/papers/38137854 | PubMed |
| 37896130 | A Reversibly Thermoresponsive, Theranostic Nanoemulgel for Tacrolimus Delivery to Activated Macrophages: Formulation and In Vitro Validation. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37896130 | PubMed |
| 37675348 | Risk factors for infection in patients with a failed kidney allograft on immunosuppressive medications. | Front Nephrol | 2023 | https://conductscience.org/library/papers/37675348 | PubMed |
| 37614233 | Comparative effects of hepatocyte growth factor and tacrolimus on acute liver allograft early tolerance. | Front Immunol | 2023 | https://conductscience.org/library/papers/37614233 | PubMed |
| 37408814 | Randomized Trial of Ciclosporin with 2-h Monitoring vs. Tacrolimus with Trough Monitoring in Liver Transplantation: DELTA Study. | J Clin Transl Hepatol | 2023 | https://conductscience.org/library/papers/37408814 | PubMed |
| 35967435 | Current status of xenotransplantation research and the strategies for preventing xenograft rejection. | Front Immunol | 2022 | https://conductscience.org/library/papers/35967435 | PubMed |
| 35707633 | Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy. | Transpl Int | 2022 | https://conductscience.org/library/papers/35707633 | PubMed |
| 34866097 | Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease. | Intern Med | 2022 | https://conductscience.org/library/papers/34866097 | PubMed |
| 34557582 | Long-term Follow-up of a Randomized Trial of Tacrolimus or Cyclosporine A Microemulsion in Children Post Liver Transplantation. | Transplant Direct | 2021 | https://conductscience.org/library/papers/34557582 | PubMed |
| 32095514 | Sequential Cohort Analysis After Liver Transplantation Shows de Novo Extended Release Tacrolimus Is Safe, Efficacious, and Minimizes Renal Dysfunction. | Transplant Direct | 2020 | https://conductscience.org/library/papers/32095514 | PubMed |
| 31070990 | Tolerogenic vaccine composited with islet-derived multipeptides and cyclosporin A induces pTreg and prevents Type 1 diabetes in murine model. | Hum Vaccin Immunother | 2020 | https://conductscience.org/library/papers/31070990 | PubMed |
| 30487677 | Cytomegalovirus infection in ulcerative colitis assessed by quantitative polymerase chain reaction: risk factors and effects of immunosuppressants. | J Clin Biochem Nutr | 2018 | https://conductscience.org/library/papers/30487677 | PubMed |
| 29997983 | New frontiers in immunosuppression. | J Thorac Dis | 2018 | https://conductscience.org/library/papers/29997983 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Authors
- Grants
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7520105
GET https://conductscience.org/api/papers/v1/7520105/cited_by?page=2